Morgan Keegan said that it believes the recent pullback on Trustmark Corporation TRMK “provides an attractive entry point for investors in what we consider to be a low-risk, high-performing franchise, with TRMK down 8.2% YTD versus a 1.6% increase in the KBW Bank index.”
“The pullback follows a 16% rise in TRMK, inline with the BKX, during Dec 2010,” Morgan Keegan writes. “At 12.0x our 2012 EPS estimate shares trade at a 16% discount to the 14.3x median of the MK small-cap banks. On a P/TBV basis TRMK trades at 1.7x, inline with the peer median. Our 12-month price target of $27 implies a multiple of 14x our 2012 EPS estimate and 2.0x YE11 TBV.
“In our view, TRMK warrants an above average valuation multiple given its solid balance sheet position, strong pre-tax pre-provision earnings (4Q12 PTPP/Assets of 2.3% versus 1.8% median of MK coverage universe) and the below average credit risk that we see here. Additionally the stock offers an extremely attractive 4%+ dividend yield, more than 3x the 1.2% median of MK Small-Cap peers.”
Trustmark Corporation closed Thursday at $22.81.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.